Trademark Overview
On Tuesday, April 2, 2024, a trademark application was filed for ORICELL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ORICELL THERAPEUTICS trademark a serial number of 98479740. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 2, 2024. This trademark is owned by ORICELL THERAPEUTICS INC.. The ORICELL THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the prevention of autoimmune diseases, non-communicable diseases, cancer, tumor, and infectious diseases; sanitary preparations for medical purposes; biological preparations for the treatment of autoimmune diseases, non-communicable diseases, cancer, tumor, and infectious diseases; pharmaceutical products for the treatment of autoimmune diseases, non-communicable diseases, cancer, tumor, and infectious diseases; biological tissue cultures for medical purposes; immunostimulants; medicinal preparations for autoimmune diseases, non-communicable diseases, cancer, tumor, and infectious diseases; pharmaceutical preparations for the treatment and prevention of autoimmune diseases, non-communicable diseases, cancer, tumor, and infectious diseases; stem cells for medical purposes; injectable pharmaceuticals for treatment of anaphylactic reactions; anti-cancer preparations; compounds for treating cancer; pharmaceutical preparations and substances for the treatment...
